Clinical Trial

Detection of Genetic Markers of Lung Cancer

Name: Detection of Genetic Markers of Lung Cancer — clinical trial record (NCT00280202)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this research study is to determine the genetic changes and immunologic changes that are involved in the development and progression of bronchogenic lung cancer.

Protocol Amendment History 18 amendments

This ClinicalTrials.gov record has been amended 18 times since 2006-01-18; most recent amendment 2025-10-22.

Trial Details

NCT Number	NCT00280202
Lead Sponsor	University of Pittsburgh Collaborators: National Institutes of Health (NIH)
Conditions	Lung Cancer
Enrollment	6,000 participants
Start Date	1996-06
Primary Completion	2050-12 (estimated)
Study Completion	2050-12 (estimated)
Updated on ClinicalTrials.gov	2025-10-24